Market Scenario:
IUCD stands for Intra-Uterine Contraceptive Devices. It is a device inserted into the uterus to prevent pregnancy. The device is T-shaped made up of flexible plastic with a coating of thin copper wire. China, ICUD was the most important tool to limit the couples to have one child. One child policy of China was introduced in 1979 favored the growth of this market till 2015. But in January 2016, a new law named “Two-child policy” become effective, which was passed by standing committee of National People’s Congress in December 2016. According to census 2010, the population change in is 7.39 per year. The market for IUCD is showing a steady rise in China because most of the women still do not want to have a second child even after the passage of second child policy. China IUCD market is expected to reach USD 20 billion in 2023 from USD 14 billion in 2016 with a CAGR of approximately 8.72% during the forecast period 2017-2023.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1306
Study objectives:
- Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
- To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
- To provide insights about factors affecting the market growth.
- To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to China
- To provide country level analysis of the market with respect to the current market size and future prospective.
- To provide country level analysis of the market for segments by diagnosis and by end users and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market.
Key Players
SMB Corporation Of India, Bayer HealthCare Pharmaceuticals Inc. (US), Mona Lisa (Belgium), Teva Women’s Health, DKT International (US).
Segmentation:
The market for IUCD in China is segmented into types which include hormonal IUD, copper IUD and other types. The end users are hospitals, Clinics and others.
Regional Analysis:
On the basis of regions market for IUCD in China is segmented into North China, Northeast China, East China, South Central China, Southwest China and Northwest China. East China account for the largest market share. It has the highest population and largest population density. The market in China is showing steady growth due to an increase in the population in all the regions.
Intended Audience
- Healthcare IT companies
- Healthcare companies
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Academic Medical Institutes and Universities
The report for IUCD of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/china-iucd-market-1306
No comments:
Post a Comment